Steroid Regimen for Moderate-to-Severe Pneumonitis
For moderate-to-severe pneumonitis after ruling out infection, initiate methylprednisolone 1-2 mg/kg/day IV for severe cases (grade 3-4) or oral prednisone 1-2 mg/kg/day for moderate cases (grade 2), then taper over 4-6 weeks. 1, 2
Initial Dosing by Severity Grade
Grade 2 (Moderate): Symptomatic, >25% lung involvement, limiting instrumental activities
- Start oral prednisone 1-2 mg/kg/day 1
- Hold immune checkpoint inhibitor therapy until improvement to grade 1 1
- Monitor at least weekly with physical exam and pulse oximetry 1
- If no clinical improvement after 48-72 hours, escalate to grade 3 treatment 1
Grade 3 (Severe): Hospitalization required, oxygen needed, >50% lung involvement
- Start methylprednisolone 1-2 mg/kg/day IV 1, 2
- Continue IV therapy for 3-5 days until clinical improvement documented 2, 3
- Permanently discontinue immune checkpoint inhibitor 1, 2
Grade 4 (Life-threatening): Intubation required
- Start methylprednisolone 1-2 mg/kg/day IV immediately 1, 2
- If no improvement after 48 hours, add second-line immunosuppressive agent 1, 2
- Options include infliximab, mycophenolate mofetil, IVIG, or cyclophosphamide 1
Transition and Tapering Protocol
Switching from IV to Oral
- Once patient stabilizes (typically 3-5 days for severe cases), transition to oral prednisone at equivalent dose 2, 3
- Continue initial dose for approximately 2 weeks total before beginning taper 3
Standard Taper Schedule
- Decrease by approximately 10 mg prednisone equivalent per week 3
- Total taper duration should be 4-6 weeks from initiation 1, 2
- Exercise extreme caution when reaching ≤10 mg daily, as relapse risk increases significantly at this threshold 2, 4
- Recrudescence typically occurs at median 6 weeks after steroid initiation when tapered to ≤10 mg 4
Critical Supportive Measures
Mandatory Prophylaxis
- Start proton pump inhibitor for all patients receiving steroids for grade 2-4 pneumonitis 2
- Initiate trimethoprim-sulfamethoxazole prophylaxis for patients receiving ≥20 mg methylprednisolone equivalent for ≥4 weeks 2
- Add calcium and vitamin D supplementation for prolonged steroid courses 2
Management of Steroid-Refractory Disease
Definition and Timing
- Steroid-refractory pneumonitis is defined as lack of clinical improvement after 48-72 hours of high-dose corticosteroids 1, 5
- This occurs in approximately 18.5% of immune checkpoint inhibitor pneumonitis cases 5
Second-Line Options
- IVIG alone demonstrates better outcomes than infliximab (43% mortality vs 100% mortality with infliximab) 5
- Consider mycophenolate mofetil or cyclophosphamide as alternatives 1, 6
- Combination IVIG plus infliximab carries 100% mortality risk and should be avoided 5
Special Considerations for Chronic Pneumonitis
Recognition
- Approximately 2% of patients develop chronic pneumonitis requiring >12 weeks of immunosuppression 1, 4
- Suspect chronic pneumonitis if symptoms recur during taper, particularly when reaching ≤10 mg prednisone 4
- Re-emergence typically occurs in the same radiographic locations on chest CT 4
Extended Management
- Some patients require low-dose prednisone maintenance (10 mg daily) to prevent recurrence 7, 4
- Median total steroid duration for chronic cases is 37 weeks (range 16-43+ weeks) 4
Essential Pitfalls to Avoid
Pre-Treatment Requirements
- Always rule out infection before initiating or escalating immunosuppression, ideally with bronchoscopy and bronchoalveolar lavage 2
- Consider empiric antibiotics if infection remains in differential diagnosis after initial workup 1
Monitoring During Taper
- Never taper faster than 10 mg prednisone per week 3
- Intensify monitoring when approaching 10 mg daily threshold 2, 4
- Repeat chest imaging in 3-4 weeks or sooner if symptoms develop 1